| 2801 |
Bone Marrow |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2022 |
Standard Therapy |
Poland |
2 months |
| 2802 |
Bone Marrow |
Allogeneic |
Shwachman-Diamond Syndrome – Sds |
Hematology |
2022 |
Standard Therapy |
Poland |
7 |
| 2803 |
Bone Marrow |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
1 |
| 2804 |
Bone Marrow |
Allogeneic |
Very Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
16 |
| 2805 |
Bone Marrow |
Allogeneic |
Wiskott-Aldrich Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
1 |
| 2806 |
Bone Marrow |
Allogeneic |
Wiskott-Aldrich Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
3 |
| 2807 |
Bone Marrow |
Allogeneic |
X-Linked Congenital Dyskeratosis |
Hematology |
2022 |
Standard Therapy |
Poland |
2 |
| 2808 |
Apheresis |
Allogeneic |
Acute Biphenotypic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
22 |
| 2809 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
41 |
| 2810 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
55 |
| 2811 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
4 |
| 2812 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
29 |
| 2813 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
59 |
| 2814 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
9 |
| 2815 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
57 |
| 2816 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
24 |
| 2817 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
36 |
| 2818 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
24 |
| 2819 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
47 |
| 2820 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
25 |
| 2821 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
29 |
| 2822 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
7 |
| 2823 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
13 |
| 2824 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
7 |
| 2825 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
8 |
| 2826 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
18 |
| 2827 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
35 |
| 2828 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
67 |
| 2829 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
69 |
| 2830 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
65 |
| 2831 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
10 |
| 2832 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
49 |
| 2833 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
75 |
| 2834 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
57 |
| 2835 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
14 |
| 2836 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
58 |
| 2837 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
54 |
| 2838 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
58 |
| 2839 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
29 |
| 2840 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
36 |
| 2841 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
57 |
| 2842 |
Apheresis |
Allogeneic |
Acute Myelofibrosis |
Hematology |
2022 |
Standard Therapy |
Poland |
55 |
| 2843 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
69 |
| 2844 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
39 |
| 2845 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
62 |
| 2846 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
69 |
| 2847 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
30 |
| 2848 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
60 |
| 2849 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
74 |
| 2850 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
45 |
| 2851 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
50 |
| 2852 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
54 |
| 2853 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
78 |
| 2854 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
42 |
| 2855 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
52 |
| 2856 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
51 |
| 2857 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
69 |
| 2858 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
25 |
| 2859 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
57 |
| 2860 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
66 |
| 2861 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
55 |
| 2862 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
50 |
| 2863 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
37 |
| 2864 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
38 |
| 2865 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
48 |
| 2866 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
54 |
| 2867 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
48 |
| 2868 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
68 |
| 2869 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
13 |
| 2870 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
68 |
| 2871 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
46 |
| 2872 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
56 |
| 2873 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
11 |
| 2874 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
59 |
| 2875 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
44 |
| 2876 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
16 |
| 2877 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
49 |
| 2878 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
65 |
| 2879 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
61 |
| 2880 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
17 |
| 2881 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
60 |
| 2882 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
55 |
| 2883 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
31 |
| 2884 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
30 |
| 2885 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
58 |
| 2886 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
74 |
| 2887 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
43 |
| 2888 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
54 |
| 2889 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
66 |
| 2890 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
61 |
| 2891 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
53 |
| 2892 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
52 |
| 2893 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
68 |
| 2894 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
68 |
| 2895 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
77 |
| 2896 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
34 |
| 2897 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
60 |
| 2898 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
68 |
| 2899 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
68 |
| 2900 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
76 |